Binaytara shared a post on LinkedIn:
“Update: Ivermectin and Cancer Treatment in 2026
With the National Cancer Institute now initiating preclinical research on ivermectin, the conversation around its role in cancer care is evolving – and getting louder.
But what do oncologists actually think right now?
In this updated analysis, we break down:
- What’s new in ivermectin research
- What cancer doctors are hearing from patients
- Why experts remain cautious despite growing attention
The bottom line: while lab research continues, there is still no proven clinical benefit in cancer treatment.
Stay informed with the latest evidence and expert perspectives.”
Other articles from Binaytara.